OPEN SOURCE PHARMA FOUNDATION
  • Home
  • About
    • History
    • Meet our team
    • Funders
    • OSPF-India >
      • Reports
  • Partners
  • Press
  • Achievements
  • Projects
    • All Projects
    • Publications
  • Ideas
    • COVID-19 Ideas
    • Other Ideas
  • Resources
  • Why We Need OSP
  • COVID-19 Response
    • Open Source COVID-19 Vaccine
    • Open Source COVID-19 Drugs: ​In Silico Drug Repurposing
    • OSP Idea Factory: C-19 Drug Discovery Hypotheses
    • Global Repurposing Platform COVID-19
    • Open Source COVID-19 Resources
  • Education
  • Events
  • Join
    • Volunteer
    • Contact us
  • Donate
Picture

RK Shandil

Scientist
Dr. Shandil, Director, FNDR, served AstraZeneca India, Bangalore, for 20 years in various scientific and managerial roles at Infection – innovative medicines group. Shandil was Head of  DMPK & Animal Sciences and led multidisciplinary teams in biology, immunology and pharmacology. He played a central role in building microbiology, cell biology and Pharmacology based drug discovery platforms relevant to drug discovery in infectious diseases.

​He was instrumental in building and managing state of the art bio-safety laboratories, a Vivarium, and validating animal models of tuberculosis, malaria and serious bacterial infections, PKPD and Pharmacology at AstraZeneca Bangalore. Shandil’s scientific leadership led to discovery and pre-clinical development of AZD 5847, an oxazolidinone class of compound that has recently completed Phase 2a/EBA clinical trial in TB patients. He led pharmacology  of several TB and malaria lead optimization (LO) programs. His  most recent & significant contribution includes discovery of Azaindoles, a yet-another clinical candidate for TB [Shirude. P et.al. Antimicrobial Agents and Chemotherapy, 2014, 58:5325-31]. He holds/shares patents for discovery of AZD 5847 and Azaindole class of compounds for the treatment of tuberculosis. He has ~30 publications in peer reviewed national and international journals, a dozen of them in very prestigious drug discovery journals like Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Tuberculosis and Science. Shandil is scientific consultant and advisor to biotech companies and Research Institutions and holds Adjunct faculty position at Transdisciplinary University, Bangalore.
​
LinkedIn  |  Email
Picture
Picture
OSPF is a supporter of the Open Source Pharma Movement and Community
Our Locations:
OSPF NIAS Drug Discovery Lab
National Institute of Advanced Studies
Indian Institute of Science Campus
Main Block, F-24
Bangalore, KA 560012
​INDIA

OSPF-Paris
Centre de Recherches Interdiciplinaires
8bis Rue Charles V
Paris, 75004
FRANCE

OSPF-USA
188 Grand Street #236
New York, NY 10013
USA
​Registered Office:
Open Source Pharma Foundation
Manyata Tech Park
MFAR Green Heart Building, Level 7
Hebbal, Outer Ring Road
Bangalore, KA 560045 
INDIA 
​
OSPF-India

Contact:
+91 80 22185052 / +91 9880193120
​info@ospfound.org
Make a donation
  • Home
  • About
    • History
    • Meet our team
    • Funders
    • OSPF-India >
      • Reports
  • Partners
  • Press
  • Achievements
  • Projects
    • All Projects
    • Publications
  • Ideas
    • COVID-19 Ideas
    • Other Ideas
  • Resources
  • Why We Need OSP
  • COVID-19 Response
    • Open Source COVID-19 Vaccine
    • Open Source COVID-19 Drugs: ​In Silico Drug Repurposing
    • OSP Idea Factory: C-19 Drug Discovery Hypotheses
    • Global Repurposing Platform COVID-19
    • Open Source COVID-19 Resources
  • Education
  • Events
  • Join
    • Volunteer
    • Contact us
  • Donate